Evidence map›Paper›PMID 30542057›Full record

ArticleScientific reports2018

Rational truncation of aptamer for cross-species application to detect krait envenomation.

Abhijeet Dhiman, Anjali Anand, Anita Malhotra, Eshan Khan, Vishal Santra, Amit Kumar, Tarun Kumar Sharma

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 48 citations in OpenAlex.

  1. RSC advances · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Research square · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Aptamer Applications in Neuroscience.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Article
  14. Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases.International journal of molecular sciences · 2020
    Review
  15. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Abhijeet DhimanDepartment of Biotechnology, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India.
Anjali AnandCentre for Biodesign and Diagnostics, Translational Health Science and Technology Institute (THSTI), Faridabad, 121001, Haryana, India.
Anita MalhotraSchool of Biological Sciences, College of Natural Sciences, Bangor University, Bangor, LL57 2UW, UK.ORCID http://orcid.org/0000-0002-1738-9046
Eshan KhanDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, 453552, India.
Vishal SantraSimultala Conservationists (Foundation for Wildlife), Nalikul, Hooghly, 712407, West Bengal, India.
Amit KumarDiscipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, 453552, India.
Tarun Kumar SharmaCentre for Biodesign and Diagnostics, Translational Health Science and Technology Institute (THSTI), Faridabad, 121001, Haryana, India. tarun@thsti.res.in.
Indian Institute of Technology Indore · INTranslational Health Science and Technology Institute · INBangor University · GBUttarakhand Technical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In majority of snakebite cases, the snake responsible for the bite remains unidentified. The traditional snakebite diagnostics method relies upon clinical symptoms and blood coagulation assays that do not provide accurate diagnosis which is important for epidemiological as well as diagnostics point of view. On the other hand, high batch-to-batch variations in antibody performance limit its application for diagnostic assays. In recent years, nucleic acid aptamers have emerged as a strong chemical rival of antibodies due to several obvious advantages, including but not limited to in vitro generation, synthetic nature, ease of functionalization, high stability and adaptability to various diagnostic formats. In the current study, we have rationally truncated an aptamer developed for α-Toxin of Bungarus multicinctus and demonstrated its utility for the detection of venom of Bungarus caeruleus. The truncated aptamer α-Tox-T2 (26mer) is found to have greater affinity than its 40-mer parent counterpart α-Tox-FL. The truncated aptamers are characterized and compared with parent aptamer for their binding, selectivity, affinity, alteration in secondary structure and limit of detection. Altogether, our findings establish the cross-species application of a DNA aptamer generated for α-Toxin of Bungarus multicinctus (a snake found in Taiwan and China) for the reliable detection of venom of Bungarus caeruleus (a snake found in the Indian subcontinent).

Indexed as

AnimalsAntibodiesAntiveninsAptamers, NucleotideBungarotoxinsBungarusChinaElapid VenomsIndiaSnake BitesTaiwanAntibodiesAntiveninsAptamers, NucleotideBungarotoxinsElapid Venoms

Identifiers

PMID30542057
PMCPMC6290766
OpenAlexW2905209257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.